Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an announcement.
China Isotope & Radiation Corporation has announced an extraordinary general meeting scheduled for September 17, 2025, to discuss the appointment of a domestic auditor and the approval of an interim dividend of RMB0.0807 per share for the first half of 2025. This meeting is significant for stakeholders as it addresses key financial decisions that could impact the company’s financial health and shareholder returns.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the field of nuclear technology, focusing on the production and distribution of isotopes and radiation-related products and services. The company is a key player in the Chinese market, providing essential components for medical, industrial, and scientific applications.
Average Trading Volume: 512,034
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.65B
For an in-depth examination of 1763 stock, go to TipRanks’ Overview page.